The basis of the FDA's decision on breast implants.
Kessler
D A
DA
Food and Drug Administration, Rockville, MD 20857.
D005260:Female; D005782:Gels; D006801:Humans; D016462:Mammaplasty / Q000009:adverse effects*; D008408:Mastectomy / Q000534:rehabilitation; D019736:Prostheses and Implants / Q000009:adverse effects*; D012828:Silicones / Q000009:adverse effects*; D012965:Sodium Chloride; D014481:United States; D014486:United States Food and Drug Administration
D005782:Gels; D012828:Silicones; D012965:Sodium Chloride